MedPath

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors.

Recruiting
Conditions
Pituitary Tumors
Registration Number
NCT05634655
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

DNA methylation is one of the important ways of protein post-translational modification.Pituitary adenoma (PA) is a benign neuroendocrine tumor that originates from adenohypophysial 45 cells, and accounts for 10%-20% of all primary intracranial tumors. However some PAs can present with high invasiveness and irregular growth, which tend to compresses the optic chiasm and third ventricle, encase the internal carotid artery, and affect hormone secretion from the pituitary gland and hypothalamus. In this study we focus on the mechanism of DNA methylation on the invasiveness of pituitary tumors.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
    1. histologically confirmed PAs, 2) Non-function pituitary adenomas
Exclusion Criteria
    1. Associated with other tumors or serious underlying diseases, 2) the medical records were not complete, or the follow-up data were missing.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
tumor recurrencethree years

During the follow-up, the tumor recurrence was observed closely

Residual tumor size1 week after surgery

Tumor size was evaluated by postoperative MRI

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

2ndAffiliated Hospital, School of Medicine

🇨🇳

Hanzhou, Zhejiang, China

2ndAffiliated Hospital, School of Medicine
🇨🇳Hanzhou, Zhejiang, China
wu qun
Contact
13605810393
2192010@zju.edu.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.